8. EVALUATION OF TREATMENT RESULTS OF SUDDEN DEAFNESS USING HYPERBARIC OXYGEN THERAPY
Main Article Content
Abstract
Objective: This study aims to evaluate the treatment results of sudden deafness (SD) using hyperbaric oxygen therapy (HBOT).
Subjects and methods: Prospective interventional study, comparing pre- and post-treatment results.
Results: The study included participants with a mean age of 54.9 ± 15.1 years and a male-to-female ratio of 1.32. Among the patients, 43.1% did not report any factors associated with the disease. The majority of patients sought treatment within 7 days (64.6%). All patients (100%) presented with symptoms of hearing loss and tinnitus, and 95.1% experienced a feeling of fullness in the ear. The rising audiogram pattern was observed in 52.3% of cases. The cases with mild hearing loss represented the most prevalent proportion at admission (76.8%). After treatment, most patients achieved a normal pure-tone audiometry (PTA) result (63.8%); with only 1 patient classified as having moderate hearing loss. 50.7% of patients demonstrated complete improvement, while 14.5% showed partial improvement based on Siegel’s criteria. The HBOT-treated group exhibited a significantly greater improvement in PTA (18.9 ± 8.6dB) compared to the non-HBOT-treated group (12.9 ± 5.0dB) (p <0.05).
Conclusion: Sudden deafness patients treated with HBOT exhibited better hearing recovery results than those treated with conventional medical interventions.
Article Details
Keywords
Sudden deafness, sudden sensorineural hearing loss, hyperbaric oxygen.
References
“Clinical practice guideline: sudden hearing
loss (update)”, Otolaryngology - Head and Neck
Surgery, 161(1_suppl): S1 - S45, 2019.
[2] Ngô Ngọc Liễn, “Mức độ nghe kém”, Giản yếu
Tai Mũi Họng, tập1, tr. 197 – 201, 1996.
[3] Choung YH, Park K, Shin YR et al.,
“Intratympanic dexamethasone injection for
refractory sudden sensorineural hearing loss”,
The Laryngoscope, 116(5):747 – 752, 2006.
[4] Filipo R, Attanasio G, Viccaro M et al.,
“Hyperbaric oxygen therapy with short duration
intratympanic steroid therapy for sudden hearing
loss” Acta Otolaryngol, 132:475-81, 2012.
[5] Cheng YF, Chu YC, Tu TY et al., “Modified
Siegel’s criteria for sudden sensorineural hearing
loss: Reporting recovery outcomes with matched
pretreatment hearing grades”, J Journal of the
Chinese Medical Association, 81(11): 1008 –
1012, 2018.
[6] Battista RA, “Intratympanic dexamethasone
for profound idiopathic sudden sensorineural
hearing loss”, Otolaryngology - Head and Neck
Surgery, 132(6): 902 – 905, 2005.
[7] Covelli E, Altabaa K, Verillaudet B et al.,
“Intratympanic steroids as a salvage therapy
for severe to profound idiopathic sudden
sensorineural hearing loss”, Acta oto –
laryngologica, 138(11): 966 – 971, 2018.
[8] Liu CS, Kang HB, Lee JC et al., “Comparison
of therapeutic results in sudden sensorineural
hearing loss with/without additional hyperbaric
oxygen therapy: a retrospective review of
465 audiologically controlled cases”, Clinical
Otolaryngology, 36(2): 121 – 128, 2011.
[9] Filipo R, Attanasio G, Viccaro M et al.,
“Hyperbaric oxygentherapy with short duration
intratympanic steroid therapy forsudden hearing
loss”. Acta Otolaryngol, 132:475–48, 2012.
[10] Eryigit B, Ziylan F, Yaz F et al., “The
effectiveness of hyperbaric oxygen in patients
with idiopathic sudden senso-rineural hearing
loss: a systematic review”. Eur Arch Oto-RhinoLaryngol,
275(12):2893–290, 2018.